BBVA
AVXL icon

Banco Bilbao Vizcaya Argentaria’s Anavex Life Sciences AVXL Stock Holding History

Banco Bilbao Vizcaya Argentaria’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-10,880
Closed -$591K – 770
2021
Q1 		$591K Buy
+10,880
New +$119K 0.01% 574

Other funds holding AVXL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
GLA
Great Lakes Advisors Chicago, Illinois $12.1B AUM 29.3% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Banco Bilbao Vizcaya Argentaria's AVXL Position: Q2 2021 in Review

Banco Bilbao Vizcaya Argentaria sold out of Anavex Life Sciences (AVXL) in Q2 2021, closing a stake of 10,880 shares — an estimated $591K sold.

Banco Bilbao Vizcaya Argentaria first reported a position in AVXL in Q1 2021 and held it in 1 quarter. The position peaked at $591K in Q1 2021. 127 funds tracked by Wall St. Rank hold AVXL as of Q2 2021.

  • Banco Bilbao Vizcaya Argentaria reported no remaining Anavex Life Sciences position as of Q2 2021 after selling out during the quarter.
  • Banco Bilbao Vizcaya Argentaria sold 10,880 Anavex Life Sciences shares in Q2 2021, an estimated $591K.
  • Banco Bilbao Vizcaya Argentaria first reported a position in Anavex Life Sciences in Q1 2021 and held it in 1 quarter.
  • Banco Bilbao Vizcaya Argentaria's Anavex Life Sciences position peaked at $591K in Q1 2021.
  • 127 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q2 2021.

Based on Banco Bilbao Vizcaya Argentaria's 13F filing for Q2 2021, filed 6 Aug 2021.